We therefore wished to examine the IL-23/IL-23R axis in further detail in NSCLC given the involvement of this pathway in airway inflammation, and its potential therapeutic utility (Miossec and Kolls, 2012). This evidence concerns the gene IL23R and non-small cell lung carcinoma.